These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 31581202)

  • 1. Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury.
    Titus DJ; Johnstone T; Johnson NH; London SH; Chapalamadugu M; Hogenkamp D; Gee KW; Atkins CM
    PLoS One; 2019; 14(10):e0223180. PubMed ID: 31581202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing cognitive recovery in chronic traumatic brain injury through simultaneous allosteric modulation of α7 nicotinic acetylcholine and α5 GABA
    Balleste AF; Sangadi A; Titus DJ; Johnstone T; Hogenkamp D; Gee KW; Atkins CM
    Exp Neurol; 2024 Sep; 379():114879. PubMed ID: 38942266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing cognitive function in chronic TBI: The Role of α7 nicotinic acetylcholine receptor modulation.
    Sangadi DK; Sangadi A; Placeres-Uray F; Titus DJ; Johnstone T; Hogenkamp D; Gee KW; Atkins CM
    Exp Neurol; 2024 Feb; 372():114647. PubMed ID: 38070724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor.
    Titus DJ; Wilson NM; Freund JE; Carballosa MM; Sikah KE; Furones C; Dietrich WD; Gurney ME; Atkins CM
    J Neurosci; 2016 Jul; 36(27):7095-108. PubMed ID: 27383587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury.
    Titus DJ; Wilson NM; Alcazar O; Calixte DA; Dietrich WD; Gurney ME; Atkins CM
    Neurobiol Learn Mem; 2018 Feb; 148():38-49. PubMed ID: 29294383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288.
    Gee KW; Olincy A; Kanner R; Johnson L; Hogenkamp D; Harris J; Tran M; Edmonds SA; Sauer W; Yoshimura R; Johnstone T; Freedman R
    J Psychopharmacol; 2017 Apr; 31(4):434-441. PubMed ID: 28196430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase inhibition rescues chronic cognitive deficits induced by traumatic brain injury.
    Titus DJ; Sakurai A; Kang Y; Furones C; Jergova S; Santos R; Sick TJ; Atkins CM
    J Neurosci; 2013 Mar; 33(12):5216-26. PubMed ID: 23516287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-concept.
    Gatson JW; Simpkins JW; Uteshev VV
    Brain Res Bull; 2015 Mar; 112():35-41. PubMed ID: 25647232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Characterization of the Novel and Selective
    Wang X; Daley C; Gakhar V; Lange HS; Vardigan JD; Pearson M; Zhou X; Warren L; Miller CO; Belden M; Harvey AJ; Grishin AA; Coles CJ; O'Connor SM; Thomson F; Duffy JL; Bell IM; Uslaner JM
    J Pharmacol Exp Ther; 2020 May; 373(2):311-324. PubMed ID: 32094294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
    Potasiewicz A; Nikiforuk A; Hołuj M; Popik P
    J Psychopharmacol; 2017 Feb; 31(2):260-271. PubMed ID: 28168926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with α7-nAChR dysfunction.
    Shenkarev ZO; Shulepko MA; Bychkov ML; Kulbatskii DS; Shlepova OV; Vasilyeva NA; Andreev-Andrievskiy AA; Popova AS; Lagereva EA; Loktyushov EV; Koshelev SG; Thomsen MS; Dolgikh DA; Kozlov SA; Balaban PM; Kirpichnikov MP; Lyukmanova EN
    J Neurochem; 2020 Oct; 155(1):45-61. PubMed ID: 32222974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization.
    Verma MK; Goel RN; Bokare AM; Dandekar MP; Koul S; Desai S; Tota S; Singh N; Nigade PB; Patil VB; Modi D; Mehta M; Gundu J; Walunj SS; Karche NP; Sinha N; Kamboj RK; Palle VP
    Eur J Pharmacol; 2021 Jan; 891():173685. PubMed ID: 33127363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction.
    Verbois SL; Hopkins DM; Scheff SW; Pauly JR
    Neuroscience; 2003; 119(4):1199-208. PubMed ID: 12831873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model.
    Sun LL; Yang TY; Wei NN; Lu W; Jiao WX; Zhou QQ; Miao YZ; Gao Q; Wang XT; Sun Q; Wang K
    Acta Pharmacol Sin; 2019 Jun; 40(6):737-745. PubMed ID: 30333556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in rats.
    Thomsen MS; El-Sayed M; Mikkelsen JD
    PLoS One; 2011; 6(11):e27014. PubMed ID: 22096516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficits of synaptic functions in hippocampal slices prepared from aged mice null α7 nicotinic acetylcholine receptors.
    Ma L; Turner D; Zhang J; Wang Q; Wang M; Shen J; Zhang S; Wu J
    Neurosci Lett; 2014 Jun; 570():97-101. PubMed ID: 24769321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JWX-A0108, a positive allosteric modulator of α7 nAChR, attenuates cognitive deficits in APP/PS1 mice by suppressing NF-κB-mediated inflammation.
    Li H; Gao J; Chang Y; Li K; Wang L; Ju C; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107726. PubMed ID: 33975230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
    Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
    J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of α7 nicotinic acetylcholine receptors persistently enhances hippocampal synaptic transmission and prevents Aß-mediated inhibition of LTP in the rat hippocampus.
    Ondrejcak T; Wang Q; Kew JN; Virley DJ; Upton N; Anwyl R; Rowan MJ
    Eur J Pharmacol; 2012 Feb; 677(1-3):63-70. PubMed ID: 22200627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays.
    Stoiljkovic M; Leventhal L; Chen A; Chen T; Driscoll R; Flood D; Hodgdon H; Hurst R; Nagy D; Piser T; Tang C; Townsend M; Tu Z; Bertrand D; Koenig G; Hajós M
    Biochem Pharmacol; 2015 Oct; 97(4):576-589. PubMed ID: 26206187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.